Article metrics

Download PDFPDF

POS1042 EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITOR, COMPARED WITH PLACEBO AND APREMILAST IN MODERATE TO SEVERE PLAQUE PSORIASIS: RESULTS FROM THE PHASE 3 POETYK PSO-1 STUDY
Free

 

Online download statistics by month:

Online download statistics by month: May 2021 to June 2022

AbstractFullPdf
May 202140020
Jun 202134074
Jul 202119094
Aug 2021160118
Sep 2021200113
Oct 202113530185
Nov 202110420154
Dec 202110180112
Jan 20228560124
Feb 202210220132
Mar 202215020249
Apr 202213690212
May 202214050184
Jun 202217180212
Total1141401983